Aquestive Therapeutics Announces Pivotal Study for Anaphylm(TM) (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA Meeting
Stock Information for IntelGenx Technologies Corp.
Loading
Please wait while we load your information from QuoteMedia.